University of Amsterdam-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Comparing Survival of Perihilar Cholangiocarcinoma After R1 Resection Versus Palliative Chemotherapy for Unresected Localized Disease

    Annals of Surgical Oncology, Vol. 31, Núm. 10, pp. 6495-6503

2022

  1. Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry

    Journal of Hepatology, Vol. 76, Núm. 5, pp. 1109-1121

  2. Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry

    Cancers, Vol. 14, Núm. 10

2021

  1. Using symptom-based case predictions to identify host genetic factors that contribute to COVID-19 susceptibility

    PLoS ONE, Vol. 16, Núm. 8

2019

  1. The challenges of primary biliary cholangitis: What is new and what needs to be done

    Journal of Autoimmunity, Vol. 105

2018

  1. MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation

    Hepatology, Vol. 67, Núm. 4, pp. 1420-1440

2015

  1. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease

    Journal of Hepatology, Vol. 63, Núm. 4, pp. 952-961

2013

  1. The significance of genetics for cholangiocarcinoma development

    Annals of Translational Medicine, Vol. 1, Núm. 3